GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been given an average rating of “Moderate Buy” by the thirteen ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $98.75.

A number of analysts have commented on the company. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th.

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors have recently modified their holdings of the business. Cathy Pareto & Associates Inc. bought a new position in GE HealthCare Technologies during the fourth quarter valued at $670,000. LMR Partners LLP bought a new position in GE HealthCare Technologies during the third quarter valued at $7,387,000. Principal Financial Group Inc. grew its holdings in GE HealthCare Technologies by 1.9% during the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after purchasing an additional 19,010 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in GE HealthCare Technologies during the third quarter valued at $1,396,000. Finally, Everence Capital Management Inc. grew its holdings in GE HealthCare Technologies by 118.2% during the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock valued at $1,475,000 after purchasing an additional 10,220 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Down 0.4 %

GEHC stock opened at $81.49 on Wednesday. The stock’s 50 day simple moving average is $87.02 and its 200 day simple moving average is $86.02. GE HealthCare Technologies has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The company has a market cap of $37.27 billion, a P/E ratio of 18.82, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, research analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.